FTC Says Shire ViroPharma’s Abuse Of FDA Process Violated Antitrust Law
WILMINGTON, Del. — The U.S. Federal Trade Commission on Feb. 7 filed an antitrust complaint against Shire ViroPharma Inc., alleging that the company engaged in abusive petitioning of and litigation with...To view the full article, register now.
Already a subscriber? Click here to view full article